Welcome to CDC stacks | Paecilomyces lilacinus Vaginitis in an Immunocompetent Patient - 14146 | Emerging Infectious Diseases
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Paecilomyces lilacinus Vaginitis in an Immunocompetent Patient
Filetype[PDF-334.79 KB]


Details:
No Related Documents.
You May Also Like:
  1. Fungal infections: a growing threat.
    Personal Author:
    Dixon, D M; McNeil, M M; Cohen, M L; Gellin, B G; La Montagne, J R;
    Published:
    1996 May-Jun
    Source:
    Public Health Rep. 111(3):226-235
    File Type:
    Filetype[PDF - 5.36 MB]
  2. Bacteria in a water-damaged building: associations of actinomycetes and non-tuberculous mycobacteria with respiratory health in occupants
    Personal Author:
    Park, J.-H.; Cox-Ganser, J. M.; White, S. K.; Laney, A. S.; Caulfield, S. M.; Turner, W. A.; Sumner, A. D.; Kreiss, K.;
    Published:
    Jan 21 2016
    Source:
    Indoor Air. 27(1):24-33.
    Description:
    We examined microbial correlates of health outcomes in building occupants with a sarcoidosis cluster and excess asthma. We offered employees a questionnaire and pulmonary function testing and collected floor dust and liquid/sludge from drain tubing t...
    File Type:
    Filetype[PDF - 348.30 KB]
  3. Infection with Scedosporium apiospermum and S. prolificans, Australia
    Personal Author:
    Cooley, Louise; Spelman, Denis; Thursky, Karin; Slavin, Monica;
    Published:
    Aug 2007
    Source:
    Emerg Infect Dis. 13(8):1170-1177.
    Description:
    Scedosporium apiospermum and S. prolificans are fungi of increasing clinical importance, particularly in persons with underlying diseases. We reviewed the records of 59 patients in Australia from whom Scedosporium spp. were isolated from June 30, 199...
    File Type:
    Filetype[PDF - 325.43 KB]
  4. Use of a new global indicator for vaccine safety surveillance and trends in adverse events following immunization reporting 2000–2015☆
    Personal Author:
    Lei, Jiayao; Balakrishnan, Madhava Ram; Gidudu, Jane F.; Zuber, Patrick L.F.;
    Published:
    Feb 14 2018
    Source:
    Vaccine. 2018; 36(12):1577-1582.
    Description:
    Reporting of adverse events following immunization (AEFI) is a key component for functional vaccine safety monitoring system. The aim of our study is to document trends in the AEFI reporting ratio globally and across the six World Health Organization...
    File Type:
    Filetype[PDF - 542.22 KB]
  5. MMWR. Morbidity and mortality weekly report, Vol. 45, no. 23, June 14, 1996
    Corporate Author:
    Centers for Disease Control and Prevention (U.S.)
    Published:
    June 14, 1996
    Series:
    MMWR. Morbidity and mortality weekly report ; v. 45, no. 23
    File Type:
    Filetype[PDF - 354.36 KB]